103 related articles for article (PubMed ID: 19740680)
21. Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis.
Elad S; Czerninski R; Fischman S; Keshet N; Drucker S; Davidovich T; Goldschmidt N
Amyloid; 2010 Mar; 17(1):27-31. PubMed ID: 20146645
[TBL] [Abstract][Full Text] [Related]
22. Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation.
Reich G; Held T; Siegert W; Kampf D; Dörken B; Maschmeyer G
Bone Marrow Transplant; 2001 Feb; 27(3):341-3. PubMed ID: 11277185
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
Perfetti V; Siena S; Palladini G; Bregni M; Di Nicola M; Obici L; Magni M; Brunetti L; Gianni AM; Merlini G
Haematologica; 2006 Dec; 91(12):1635-43. PubMed ID: 17145600
[TBL] [Abstract][Full Text] [Related]
24. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
[TBL] [Abstract][Full Text] [Related]
25. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
26. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
[TBL] [Abstract][Full Text] [Related]
27. Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience.
Chow LQ; Bahlis N; Russell J; Chaudhry A; Morris D; Brown C; Stewart DA
Bone Marrow Transplant; 2005 Oct; 36(7):591-6. PubMed ID: 16062177
[TBL] [Abstract][Full Text] [Related]
28. Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.
Sanchorawala V; Seldin DC; Magnani B; Skinner M; Wright DG
Bone Marrow Transplant; 2005 Oct; 36(7):597-600. PubMed ID: 16044137
[TBL] [Abstract][Full Text] [Related]
29. Anesthetic management of a combined heart and liver transplantation in an amyloidotic patient: a case report.
Barrio IM; Mtnez de Guereñu MA; Real MI; Del Campo I; Pérez-Cerdá F; Moreno E
Transplant Proc; 2007 Sep; 39(7):2458-9. PubMed ID: 17889217
[TBL] [Abstract][Full Text] [Related]
30. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
31. [Kidney transplantation in a case of amyloidosis].
Cuvelier R; Pirson Y; Cosyns JP; Squifflet JP; Alexandre GP; van Ypersele de Strihou C
Nephrologie; 1986; 7(2):63-6. PubMed ID: 3526167
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid.
Eriksson M; Büttner J; Todorov T; Yumlu S; Schönland S; Hegenbart U; Kristen AV; Dengler T; Lohse P; Helmke B; Schmidt H; Röcken C
Am J Surg Pathol; 2009 Jan; 33(1):58-65. PubMed ID: 18830126
[TBL] [Abstract][Full Text] [Related]
33. Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis.
Girnius S; Seldin DC; Skinner M; Finn KT; Quillen K; Doros G; Sanchorawala V
Ann Hematol; 2010 Jun; 89(6):579-84. PubMed ID: 20012043
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis.
Fernández de Larrea C; Cibeira MT; Rovira M; Rosiñol L; Esteve J; Bladé J
Eur J Haematol; 2008 Feb; 80(2):182-4. PubMed ID: 18081703
[TBL] [Abstract][Full Text] [Related]
35. Fibril protein fragmentation pattern in systemic AL-amyloidosis.
Enqvist S; Sletten K; Westermark P
J Pathol; 2009 Dec; 219(4):473-80. PubMed ID: 19771564
[TBL] [Abstract][Full Text] [Related]
36. Ultrastructural analysis of amyloidoma.
Garcia CA; Abell-Aleff PC; Gamb SI; Miller DV
Ultrastruct Pathol; 2009; 33(3):123-7. PubMed ID: 19479652
[TBL] [Abstract][Full Text] [Related]
37. Heart transplantation in patients with amyloidosis: single-center experience.
Alloni A; Pellegrini C; Ragni T; Goggi C; D'Armini AM; Rinaldi M; Viganò M
Transplant Proc; 2004 Apr; 36(3):643-4. PubMed ID: 15110619
[TBL] [Abstract][Full Text] [Related]
38. [Heart transplantation in AL amyloidosis].
Dahlberg P; Bartfay SE; Karason K; Mellqvist UH; Bollano E
Lakartidningen; 2018 Mar; 115():. PubMed ID: 29583159
[TBL] [Abstract][Full Text] [Related]
39. Cardiac amyloidosis: what are the indications for transplant?
Bradshaw SH; Veinot JP
Curr Opin Cardiol; 2012 Mar; 27(2):143-7. PubMed ID: 22314298
[TBL] [Abstract][Full Text] [Related]
40. Amyloid heart disease: a brief review of treatment options.
Dubrey SW
Postgrad Med J; 2012 Dec; 88(1046):700-5. PubMed ID: 22745180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
